TRP

TISSUE REP FPO [TRP]
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical drug in Phase III clinical trial for the treatment of chronic wounds and venous leg ulcers; and TR Pro+, a post-procedure gel for the aftercare of acute wounds, and aesthetic and medical procedures. Tissue Repair Ltd was incorporated in 2012 and is based in Chatswood, Australia.
Healthcare · ASX Small Cap
$0.0950 -13.6%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when TRP triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track TRP — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Volume surging at 4.0x normal while price falls — heavy selling pressure
  • Sitting near support — this level has held before and could attract buyers again
  • Took a hit — down 13.6% over the last 5 days
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Adequate cash runway (6 quarters)
  • 4C filed 2026-04-30
  • Low P/S ratio (1.7x)
  • Strong revenue growth (+114%)
  • EPS estimates revised downward (-10pts)
  • Near 52-week low (0% of range)
  • Micro-cap ($5-20M) - high risk
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 64% over the past year
  • Revenue growing at +114% — the top line is moving in the right direction
  • Altman Z-Score distress zone (1.09 < 1.81, low-confidence approx)
  • Liquidity risk: 8 zero-volume days in last 20
  • RBA hiking (-3pts)

Risk Signals

  • MACD crossed bearish — momentum is fading
  • Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
  • Below the 200-day average — the long-term trend is still working against it
  • Deeply negative margins (-114%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-3.77%/day)
Ask Scout AI about TRP
"What's driving TRP today?" "How does TRP compare to peers?" "Key risks for TRP?"
3 free messages/day · Unlimited with Pro

Key Metrics

$5.7M
Market Cap
35K
Avg Volume
4.0x
Vol Ratio
$0.10 — $0.48
52-Week Range
N/A
Short Interest
6 qtrs
Cash Runway
-28.1%
ROE
-113.9%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 57%
LLeader vs LaggardlaggardRS: -14
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:TRP vs IDTTRP vs ADRTRP vs LDX
Scout Pro — Deeper Analysis for TRP
Try Pro free for 30 days
Share this analysis

Track TRP and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required